STOCK TITAN

Cannabis Bioscience International Holdings, Inc. - $CBIH STOCK NEWS

Welcome to our dedicated page for Cannabis Bioscience International Holdings news (Ticker: $CBIH), a resource for investors and traders seeking the latest updates and insights on Cannabis Bioscience International Holdings stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Cannabis Bioscience International Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Cannabis Bioscience International Holdings's position in the market.

Rhea-AI Summary

Vita Biotech Research has partnered with Cannabis Bioscience International Holdings (OTCMKTS: CBIH) to fund CBIH's clinical studies, enhancing data integrity and speeding up progress. Vita Biotech will act as a financial subsidiary, supporting data collection trials important for evaluating CBIH's formulations. This collaboration allows CBIH to isolate each medical formulation into a unique legal entity, a risk management strategy that simplifies financing and partnerships. Texas was chosen for patent housing due to its favorable judicial environment. The partnership aims to improve statistical significance, uphold ethical standards, and bolster CBIH's research credibility.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
60%
Tags
-
Rhea-AI Summary

Vita Biotech has partnered with Cannabis Bioscience International Holdings (OTC Pink: CBIH) to fund CBIH's clinical studies. This alliance will expedite CBIH's data collection for evaluating their formulations' efficacy and safety, facilitating the company's scientific and commercial objectives. The partnership involves Vita Biotech acting as a financial subsidiary, aiding in streamlined financing, and risk management by isolating each medical formulation into a unique legal entity. Texas has been chosen for patent housing due to its favorable business environment. Both companies maintain ethical standards and prioritize data integrity, aiming to enhance patient care and credibility in medical cannabis research.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
60%
Tags
-
Rhea-AI Summary

Cannabis Bioscience International Holdings (CBIH) has engaged StoneBridge Advisory for a comprehensive company valuation. StoneBridge, a Colorado-based firm with over 30 years of experience, specializes in business valuations and mergers and acquisitions. This valuation aims to enhance strategic decision-making, attract investments, and facilitate negotiations, especially in light of potential U.S. federal reclassification of cannabis.

CBIH anticipates the valuation will help identify growth opportunities and navigate the evolving medical cannabis market. The company is preparing to capitalize on new business partnerships, funding, and banking services stemming from possible legal changes. The valuation is seen as essential for market comparison and long-term sustainability.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.67%
Tags
none
Rhea-AI Summary

Cannabis Bioscience International Holdings (CBIH) has appointed Mr. John E. Jones as its new Treasurer and Director. Mr. Jones brings a wealth of experience from his successful career in the business sector, with a focus on strategic acquisitions, mergers, and capital projects. His expertise is expected to bolster CBIH's position in the cannabis industry, particularly in cannabinoid research and innovation.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.29%
Tags
none
-
Rhea-AI Summary
Cannabis Bioscience International Holdings, Inc. (CBIH) initiates a clinical trial for Orthocann, a new intra-articular cannabinoid-based injection for knee osteoarthritis. The company aims to assess its efficacy in treating knee cartilage damage and providing relief without the adverse effects of corticosteroid injections.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Cannabis Bioscience International Holdings, Inc. (CBIH) announces the retirement of one billion shares by its CEO, Dante Picazo, contributing to a reduction in outstanding shares to approximately 9.4 billion. The market price of the shares is valued at $5 million, aiming to increase shareholder value. This move follows previous contributions by current management, totaling 5.5 billion shares since 2019, without a reverse stock split. The Company's commitment to innovation in medical formulations and biotechnology, supported by AI algorithms, reflects a focus on market integrity and scientific research.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Cannabis Bioscience International Holdings (CBIH) appoints Brian Cuban as Advisory Board Member, bringing legal, corporate leadership, and mental health expertise. Cuban, brother of Mark Cuban, is a lawyer, author, and advocate with a history of recovery. His addition aims to enhance CBIH's mission of advancing cannabinoid medicine and improving patient care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.29%
Tags
management
-
Rhea-AI Summary
Cannabis Bioscience International Holdings (CBIH) partners with Bull in Advantage for Investor Relations services.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.67%
Tags
none
-
Rhea-AI Summary
Cannabis Bioscience International Holdings, Inc. (CBIH) CEO Dante Picazo sends a letter to shareholders, highlighting the company's progress in developing formulations for various medical conditions, including osteoarthritis and depressive disorders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.11%
Tags
none
Rhea-AI Summary
Cannabis Bioscience International Holdings (CBIH) achieved SEC effectiveness for its Form S-1 registration statement, aiming to start its own cannabis clinical trials using AI programs to optimize research processes and acquire clinical evidence for its intellectual property cannabinoid formulations. The company plans to treat cancer, PTSD, COVID-19, Herpes Zoster, chronic pain, and other conditions. CBIH is dedicated to representing Texas as a leader in the medicinal cannabis industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.5%
Tags
none
Cannabis Bioscience International Holdings, Inc.

OTC:CBIH

CBIH Rankings

CBIH Stock Data

6.78M
5.64B
39.71%
Other Crushed and Broken Stone Mining and Quarrying
Mining, Quarrying, and Oil and Gas Extraction
Link
United States of America
Houston